Hebrew
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
עמוד 1 מ 45 תוצאות
Use of boric acid in boron neutron capture therapy for liver cancer
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
The present invention relates to a boron drug of boron neutron capture therapy (BNCT) for treating liver cancer, and particularly to a new use of using boric acid as the boron drug of BNCT for treating liver cancer.
BACKGROUND OF THE INVENTION
Using the boron neutron capture
Enriched 10-boron composition for cancer therapy and a method of synthesizing the same
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
CROSS-REFERENCE TO RELATED APPLICATION
This application claims the priority under 35 USC 35 119(e) of U.S. Provisional Application Ser. No. 61/712,710 filed Oct. 11, 2012 which included by reference herein.
BACKGROUND
1. Technical Field
The embodiments herein generally relate to a cancer treatment
Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
BACKGROUND
1. Field of the Disclosure
The present disclosure relates to novel 4-hydroxytamoxifen and endoxifen prodrugs and the synthesis of the same. Further, the present disclosure teaches the utilization of the novel 4-hydroxytamoxifen and endoxifen prodrugs in a treatment for breast cancer.
The
Treatment of urogenital cancer with boron neutron capture therapy
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
BACKGROUND OF THE INVENTION
A. DNCT and its Prior Uses
The goal of cancer therapy is to achieve a degree of selectivity that spares normal cells and destroys all malignant ones, since even a small number of remaining malignant cells can lead to recurrence, metastasis, and death. A two-component or
Treatment of urogenital cancer with boron neutron capture therapy
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
The goal of cancer therapy is to achieve a degree of selectivity that spares normal cells and destroys all malignant ones, since even a small number of remaining malignant cells can lead to recurrence, metastasis, and death. A two-component or binary system comprised of constituents that alone are
Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
The invention herein is directed to chiral specific boron-containing compounds, such as boronate, boronate esters, boranamines, boranediamines, boranamine thioesters, and boronic mono/di-thioesters, as anti-cancer or anti-amyloidosis agents, as well as their compositions,
Boron cluster-modified PEG lipid derivative, and molecular assembly using same
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
TECHNICAL FIELD
The present invention relates to a PEG lipid derivative useful as a drug carrier that selectively accumulates in a tumor tissue and delivering boron, and a molecular assembly using the same.
BACKGROUND ART
Boron neutron capture therapy (hereinafter, also referred to as "BNCT") for
Boron neutron capture enhancement of fast neutron therapy
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
The present invention relates to the use of boron-containing agents in boron neutron capture therapy killing of target cells. More particularly, this invention relates to boron neutron capture enhancement of fast neutron radiation therapy.
BACKGROUND OF THE INVENTION
Shortly
Boron heterocycle steroid mimics and associated pharmaceutical compositions and methods of use
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
TECHNICAL FIELD
The present invention relates generally to pharmaceuticals, and more particularly relates to novel pharmaceutical agents in the form of boron heterocycle steroid mimics. The invention additionally relates to pharmaceutical compositions containing a compound of the invention, and to
Boron heterocycle steroid mimics and associated pharmaceutical compositions and methods of use
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
TECHNICAL FIELD
The present invention relates generally to pharmaceuticals, and more particularly relates to novel pharmaceutical agents in the form of boron heterocycle steroid mimics. The invention additionally relates to pharmaceutical compositions containing a compound of the invention, and to
Boron-containing porphyrin compounds and their uses
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
TECHNICAL FIELD
This invention pertains to boron-containing porphyrin compounds, and their uses in fields including boron neutron capture therapy of tumors, radiotherapy of tumors, photodynamic therapy of tumors and other diseased tissue, imaging tissues, and inactivation of bacteria and
Method for improvement of radiation therapy of malignant tumors
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
FIELD OF THE INVENTION
The present invention relates generally to a new method for the improvement of radiation therapy of malignant tumors.
BACKGROUND OF THE INVENTION
Typically, a patient with a malignant tumor undergoes preliminary therapy to greatly reduce the body burden of the malignant cells.
Composition and method for detecting and treating cancer
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
SUMMARY OF THE INVENTION
This invention relates to methods for detecting and treating abnormal tissue growth, such as benign and malignant tumors in living beings including, but not limited to the use of drug units formed of monoclonal antibodies containing or combined with units or small quantities
Boron neutron capture therapy using pre-targeting methods
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to improved methods for targeting boron atoms to tumor cells for effecting boron neutron capture therapy (BNCT). BNCT is a binary system designed to deliver ionizing radiation to tumor cells by neutron irradiation of
Boron neutron capture therapy using pre-targeting methods
רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to improved methods for targeting boron atoms to tumor cells for effecting boron neutron capture therapy (BNCT). BNCT is a binary system designed to deliver ionizing radiation to tumor cells by neutron irradiation of
המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע
- עובד ב 55 שפות
- מרפא צמחי מרפא מגובה על ידי מדע
- זיהוי עשבי תיבול על ידי דימוי
- מפת GPS אינטראקטיבית - תייגו עשבי תיבול במיקום (בקרוב)
- קרא פרסומים מדעיים הקשורים לחיפוש שלך
- חפש עשבי מרפא על פי השפעותיהם
- ארגן את תחומי העניין שלך והתעדכן במחקר החדשות, הניסויים הקליניים והפטנטים
הקלד סימפטום או מחלה וקרא על צמחי מרפא שעשויים לעזור, הקלד עשב וראה מחלות ותסמינים שהוא משמש נגד.
* כל המידע מבוסס על מחקר מדעי שפורסם
